VistaGen Therapeutics Inc (NASDAQ:VTGN)

2.33
Delayed Data
As of Oct 21
 -0.02 / -0.85%
Today’s Change
0.61
Today|||52-Week Range
3.55
+20.10%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Dotson Jerrold D
Chief Financial Officer, Secretary & VP
Sale9/07/202130,000$3.12$93.6K-25.48%
Dotson Jerrold D
Chief Financial Officer, Secretary & VP
Buy6/30/202178,918$1.00$78.9K-25.71%
Snodgrass H Ralph
President & Chief Scientific Officer
Buy8/17/20213,750$2.73$10.2K-13.65%
Singh Shawn K
Chief Executive Officer
Gift6/30/20215,000$1.95$9.8K-25.71%
Singh Shawn K
Chief Executive Officer
Buy4/23/20215,000$1.50$7.5K+14.71%
Snodgrass H Ralph
President & Chief Scientific Officer
Gift6/30/20213,391$1.95$6.6K-25.71%
Dotson Jerrold D
Chief Financial Officer, Secretary & VP
Gift6/30/20213,044$1.95$5.9K-25.71%
Smith Mark A /vistagen/
Chief Medical Officer
Gift6/30/20212,260$1.95$4.4K-25.71%
Dotson Jerrold D
Chief Financial Officer, Secretary & VP
Buy6/30/20219,824$0.40$3.9K-25.71%
Saxe Jon Sheldon
Director
Buy3/19/20212,500$1.50$3.8K-0.43%
Page of 2